Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab

NCT06287229

Conditions
B-cell Acute Lymphocytic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +20 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)

NCT04989621

Conditions
Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
  • Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
View Trial Details
Recruiting

Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients

NCT07363252

Conditions
Disease Attributes, EGFR-mutated NSCLC, Pathologic Processes, +2 more
Locations
  • IRCCS Oncologico Giovanni Paolo II Bari, BA, Italy
  • Asst Papa Giovanni Xxiii Sc Oncologia Bergamo, BG, Italy
  • UOC di Oncologia Medica IRCCS - Policlinico S. Orsola Malpighi Bologna, BO, Italy
  • Humanitas Istituto Clinico Catanese Contrada Cubba Misterbianco, CT, Italy
View all 25 locations
View Trial Details
Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

NCT02974647

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Miami Miami, Florida, United States
  • Northwestern Medicine (Data collection and specimen analysis) Chicago, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details

Related conditions